Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd. (PHH) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
phh · pe ratio · data through Oct 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Park Ha Biological Technology Co., Ltd. (PHH) measures how much investors pay for each dollar of the company's trailing earnings. PHH's current PE ratio of N/A is calculated by dividing its stock price of $0.39 by its TTM earnings per share of -$40.95.
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-10-31
PE Ratio History
2002 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 11 fiscal years · Front-end computedMinQ1 · 25%0.0x
MedianQ3 · 75%0.0x
Max
At N/A, PHH's current P/E is lower than in 0% of its annual fiscal year readings over the past 11 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Household & Personal Products · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Park Ha Biological Technology Co., Ltd.You PHH | $10M | N/A | — | -$40.95 |
 AgriFORCE Growing Systems Ltd. AGRI | $2M | N/A | — | -$2.03 |
 Bon Natural Life Limited BON | $8M | N/A | — | -$0.72 |
 Edible Garden AG Incorporated EDBL | $0M | N/A | — | -$6.02 |
 Healthy Choice Wellness Corp. HCWC | $4M | N/A | — | -$0.24 |
 IP Strategy Holdings, Inc. IPST | $2M | N/A | — | -$15.98 |
 Classover Holdings, Inc. Class B Common Stock KIDZ | $2M | N/A | — | -$14.31 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-10-31Latest FY2024 | 0.00x | $0.02 | +78.0% | |
2023-10-31 FY2023 | 0.00x | $0.03 | -77.5% | |
2022-10-31 FY2022 | 0.00x | $0.01 | — | |
2021-10-31 FY2021 | — | $-0.02 | — | |
2017-12-31 FY2017 | — | $-4.14 | — | |
2016-12-31 FY2016 | — | $-3.60 | — | |
2015-12-31 FY2015 | — | $-2.37 | — | |
2014-12-31 FY2014 | — | $-3.36 | — | |
2013-12-31 FY2013 | 0.00x | $2.35 | -74.6% | |
2012-12-31 FY2012 | 0.00x | $0.60 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Park Ha Biological Technology Co., Ltd. (PHH) measures how much investors pay for each dollar of the company's trailing earnings. PHH's current PE ratio of N/A is calculated by dividing its stock price of $0.39 by its TTM earnings per share of -$40.95.
Frequently asked questions
PHH pe ratio · 6 questionsPHH's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.39 and TTM EPS of -$40.95. Data sourced from Financial Modeling Prep via PHH's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Park Ha Biological Technology Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08